CompanyTrack
E

ERGOMED GROUP LIMITED

Active Guildford

Other professional, scientific and technical activities n.e.c.

1,525 employees Website
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
E

ERGOMED GROUP LIMITED

Other professional, scientific and technical activities n.e.c.

Founded 29 Sept 2000 Active Guildford, England 1,525 employees ergomedplc.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
Accounts Submitted 3 Oct 2025
Confirmation Statement Submitted 10 Jun 2025
Net assets £83.78M £974.00K 2023 year on year
Total assets £133.62M £4.27M 2023 year on year
Total Liabilities £49.84M £5.24M 2023 year on year
Charges 5
2 outstanding 3 satisfied

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

1 Occam Court Surrey Research Park Guildford GU2 7HJ England

Office (Guildford, Surrey)

1 Occam Court, The Surrey Research Park

Credit Report

Discover ERGOMED GROUP LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£14.95M

Decreased by £4.15M (-22%)

Net Assets

£83.78M

Decreased by £974.00k (-1%)

Total Liabilities

£49.84M

Increased by £5.24M (+12%)

Turnover

£160.07M

Increased by £36.21M (+29%)

Employees

1525

Increased by 88 (+6%)

Debt Ratio

37%

Increased by 3 (+9%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

224 Allotments 44,347,965 Shares £47.25m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Nov 20254,177,957£4.18m£1
11 Nov 20251£1.02£1.02
11 Nov 20251£1.71£1.71
25 Sept 202510,065,534£10.07m£1
25 Sept 20251£1.88£1.88

Officers

Officers

3 active 30 resigned
Status
Joanne BletcherSecretaryUnknownUnknown18 Sept 2019Active
Miroslav ReljanovicDirectorCroatianCroatia6725 Apr 2001Active
Sybrand Gerhardus PretoriusDirectorAmericanUnited States557 Aug 2024Active

Shareholders

Shareholders (1)

Eden Acquisitionco Limited
100.0%
70,650,07710 Jun 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Eden Acquisitionco Limited

United Kingdom

Active
Notified 13 Nov 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Miroslav Reljanovic

Ceased 30 Oct 2019

Ceased

Group Structure

Group Structure

EDEN ACQUISITIONCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EDEN HOLDCO 3 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EDEN HOLDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EDEN HOLDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EDEN TOPCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EIGHTPLATFORM V LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ERGOMED GROUP LIMITED Current Company
ADAMAS CONSULTING GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ERGOMED CLINICAL RESEARCH LIMITED united kingdom shares 75 to 100 percent
ERGOMED US HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
HAEMOSTATIX LIMITED united kingdom shares 75 to 100 percent
PRIMEVIGILANCE LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
SOUND OPINION LIMITED united kingdom shares 75 to 100 percent

Charges

Charges

2 outstanding 3 satisfied

Documents

Company Filings

DateCategoryDescriptionDocument
18 Nov 2025MortgageMortgage Satisfy Charge FullView(1 page)
13 Nov 2025CapitalAllotment of shares (GBP 848,935.71) on 2025-11-11View(3 pages)
3 Oct 2025CapitalAllotment of shares (GBP 807,156.12) on 2025-09-25View(3 pages)
3 Oct 2025AccountsAnnual accounts made up to 2024-12-31View(38 pages)
12 Aug 2025OfficersTermination of Jonathan Andrew Curtain as director on 2025-07-31View(1 page)
18 Nov 2025 Mortgage

Mortgage Satisfy Charge Full

13 Nov 2025 Capital

Allotment of shares (GBP 848,935.71) on 2025-11-11

3 Oct 2025 Capital

Allotment of shares (GBP 807,156.12) on 2025-09-25

3 Oct 2025 Accounts

Annual accounts made up to 2024-12-31

12 Aug 2025 Officers

Termination of Jonathan Andrew Curtain as director on 2025-07-31

Recent Activity

Latest Activity

Mortgage Satisfy Charge Full

3 months ago on 18 Nov 2025

Allotment of shares (GBP 848,935.71) on 2025-11-11

3 months ago on 13 Nov 2025

Allotment of shares (GBP 807,156.12) on 2025-09-25

4 months ago on 3 Oct 2025

Annual accounts made up to 2024-12-31

4 months ago on 3 Oct 2025

Termination of Jonathan Andrew Curtain as director on 2025-07-31

6 months ago on 12 Aug 2025